Xconomy Boston

Surface Logix, Inc. Receives $20,000,000 New Round

  • Feed Type
  • Date
    3/9/2009
  • Company Name
    Surface Logix, Inc.
  • Mailing Address
    50 Soldiers Field Place Brighton, MA 02135
  • Company Description
    Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders.
  • Website
    http://www.surfacelogix.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Surface Logix Inc. uses its expertise in biophysical chemistry to create and develop novel small molecule drugs to treat metabolic and cardiovascular disease. For more information
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    HBM Bioventures
  • Venture Investor
    HealthCare Ventures
  • Venture Investor
    Intel Capital
  • Venture Investor
    Venrock
  • Venture Investor
    Unilever
  • Venture Investor
    MPM Capital

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.